Expression of Neuropeptides, Neurotrophins, and Neurotransmitters in the Skin of Patients with Atopic Dermatitis and Psoriasis

Bulletin of Experimental Biology and Medicine

Volumn 159, Issue 3, 2015, Pages 318-322

  Kubanov, A A ^a   Katunina, O R ^a   Chikin, V V ^a  

^a Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology   (Russian Federation)

Author keywords

amphiregulin; atopic dermatitis; itch; psoriasis; semaphorin 3A

Indexed keywords

AMPHIREGULIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER; NEUROTROPHIN; PROTEIN PGP9.5; PROTEIN TYROSINE KINASE A; SEMAPHORIN 3A; SUBSTANCE P; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NERVE GROWTH FACTOR; NERVE PROTEIN; NGFR PROTEIN, HUMAN; SEMAPHORIN; UBIQUITIN THIOLESTERASE; UCHL1 PROTEIN, HUMAN;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE FIBER; PROTEIN EXPRESSION; PSORIASIS; SKIN DEFECT; SKIN NERVE; SKIN PENETRATION; SKIN PRURITUS; ADOLESCENT; AGED; BIOPSY; METABOLISM; MIDDLE AGED; SKIN; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMPHIREGULIN; BIOPSY; CALCITONIN GENE-RELATED PEPTIDE; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PSORIASIS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, NERVE GROWTH FACTOR; SEMAPHORIN-3A; SEMAPHORINS; SKIN; UBIQUITIN THIOLESTERASE; YOUNG ADULT;

EID: 84938980380     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-015-2951-4     Document Type: Article

References (15)

1. O. R. Katunina, V. V. Chikin, L. F. Znamenskaya, and L. A. Inoyatova, Vestn. Dermatol. Venerol., No. 5, 91-101 (2013).
2. K. M. Albers, D. E. Wright, and B. M. Davis, J. Neurosci., 14, No. 3, Pt 2, 1422-1432 (1994).
3. J. Buddenkotte and M. Steinhoff, Allergy, 65, No. 7, 805-821 (2010).
4. S. E. Chang, S. S. Han, H. J. Jung, and J. H. Choi, Br. J. Dermatol., 156, No. 6, 1272-1277 (2007).
5. V. D. Dontchev and P. C. Letourneau, J. Neurosci., 22, No. 15, 6659-6669 (2002).
6. L. Garibyan, C. G. Rheingold, and E. A. Lerner, Dermatol. Ther., 26, No. 2, 84-91 (2013).
7. A. Jarvikallio, I. T. Harvima, and A. Naukkarinen, Arch. Dermatol. Res., 295, No. 1, 2-7 (2003).
8. A. Nilsson and M. Kanje, Neuroreport, 16, No. 3, 213-218 (2005).
9. E. M. Peters, U. Raap, P. Welker, et al., Horm. Metab. Res., 39, No. 2, 110-124 (2007).
10. C. Pincelli and M. Steinhoff, J. Invest. Dermatol., 133, No. 6, 1465-1467 (2013).
11. U. Raap and A. Kapp, Curr. Opin. Allergy Clin. Immunol., 5, No. 5, 419-424 (2005).
12. D. Roosterman, T. Goerge, S. W. Schneider, et al., Physiol. Rev., 86, No. 4, 1309-1379 (2006).
13. D. Roggenkamp, S. Falkner, F. Stab, et al., J. Invest. Dermatol., 132, No. 7, 1892-1900 (2012).
14. A. J. Shepherd, J. E. G. Downing, and J. A. Miyan, Immunology, 116, No. 2, 145-163 (2005).
15. M. Steinhoff, S. Stander, S. Seeliger, et al., Arch. Dermatol., 139, No. 11, 1479-1488 (2003).